CS logo
small CS logo
General Hospital Sremska Mitrovica

Sremska Mitrovica, Serbia
Hospital in Sremska Mitrovica
Stari šor 65, Sremska Mitrovica 22000

About General Hospital Sremska Mitrovica


"Opšta Bolnica"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Arena Pharmaceuticals
2
Pfizer
2
Boehringer Ingelheim
1
Can-Fite BioPharma
1
Eli Lilly and Company
1
Mark Coburn
1
Total Rows: 6

Clinical Trials at General Hospital Sremska Mitrovica


During the past decade, General Hospital Sremska Mitrovica conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1122223300000000Started TrialsCompleted Trails201720182019202001234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Periinterventional Outcome Study in the Elderly
2017-10-01
2019-01-30
Completed
9,500
CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis
2018-09-15
2022-04-27
Completed
528
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
2018-06-18
2024-03-19
Recruiting
1,281
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
2019-06-13
2022-02-16
Completed
433
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
2019-09-05
2027-01-31
Recruiting
900
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
2020-09-15
2021-12-07
Completed
354
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
2020-01-13
2031-08-01
Recruiting
1,115
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
2020-12-16
2023-08-31
Active, not recruiting
6,522

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "General Hospital Sremska Mitrovica" #1 sponsor was "Arena Pharmaceuticals" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Can-Fite BioPharma" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Sremska Mitrovica" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsArena Pharmaceuticals: 2Arena Pharmaceuticals: 2Pfizer: 2Pfizer: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Can-Fite BioPharma: 1Can-Fite BioPharma: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Mark Coburn: 1Mark Coburn: 1

Created with Highcharts 11.1.0Top CollaboratorsArena is a whollyowned subsidiary ofPfizer: 2Arena is a whollyowned subsidiary ofPfizer: 2Eli Lilly and Company: 1Eli Lilly and Company: 1

Clinical Trials Conditions at General Hospital Sremska Mitrovica


According to Clinical.Site data, the most researched conditions in "General Hospital Sremska Mitrovica" are "Ulcerative Colitis" (4 trials), "Complication, Postoperative" (1 trials), "Crohn's Disease" (1 trials), "Mortality" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "General Hospital Sremska Mitrovica" in a lesser frequency.

Clinical Trials Intervention Types at General Hospital Sremska Mitrovica


Most popular intervention types in "General Hospital Sremska Mitrovica" are "Drug" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Etrasimod" (4 trials), "Apremilast 30mg" (1 trials), "CF101 2mg" (1 trials) and "CF101 3mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at General Hospital Sremska Mitrovica


The vast majority of trials in "General Hospital Sremska Mitrovica" are 8 trials for "All" genders.

Clinical Trials Status at General Hospital Sremska Mitrovica


Currently, there are NaN active trials in "General Hospital Sremska Mitrovica". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in General Hospital Sremska Mitrovica, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in General Hospital Sremska Mitrovica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Recruiting: 3Recruiting: 3Active, not recruiting: 1Active, not recruiting: 1